EMA — authorised 25 August 2020
- Marketing authorisation holder: GlaxoSmithKline (Ireland) Limited
- Status: approved
🇪🇺 Blenrep in European Union
EMA authorised Blenrep on 25 August 2020
Marketing authorisation
Blenrep in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Blenrep approved in European Union?
Yes. EMA authorised it on 25 August 2020.
Who is the marketing authorisation holder for Blenrep in European Union?
GlaxoSmithKline (Ireland) Limited holds the EU marketing authorisation.